NASDAQ$SERA

Sera Prognostics Inc-A · Q2 2023 earnings

Q2 2023 earnings · · Investor relations

Briefing

Reported financial results for the second quarter of 2023.

Sera Prognostics reported second quarter 2023 revenue of $123,000, a net loss of $10.5 million, and cash, cash equivalents, and available-for-sale securities of approximately $92.1 million as of June 30, 2023.

  • Announced leadership changes and commercial actions in May 2023 to optimize business for market success.
  • Appointed Zhenya Lindgardt as interim President and CEO, and Austin Aerts as interim CFO.
  • Engaged leading strategy house to rigorously evaluate best pathways toward enhanced revenue at significant reduced cost.
  • Executed select headcount reductions in commercial organization to better map current commercial costs in line with refined focus.

Headline financials

Total Revenue

$123K

Previous: $78K+57.7%
EPS (adj)

-$0.34

Previous: -$0.37+8.1%
Capital Expenditures

-$86K

Previous: -$226K+61.9%
Free Cash Flow

-$10.6M

Previous: -$11.7M+9.5%
Net Income

-$10.5M

Previous: -$11.5M+8.5%
Operating Income

-$11.5M

Previous: -$11.7M+2.4%
Gross Profit

$43K

Previous: $22K+95.5%
Cash & Equivalents

$32.3M

Previous: $53.9M-40.1%
Total Assets

$96.7M

Previous: $125M-22.7%
Stock-Based Comp

$1.44M

Previous: $1.21M+18.6%

Revenue & EPS history

Sera Prognostics · Revenue · Quarterly

$123K

Q2 2023+57.7%vs Q2 2022
Beat estimate in 3 of 15 quarters(20%)
ActualEstimate

Forward guidance

Sera Prognostics is pursuing a disciplined commercial approach to broaden adoption of their PreTRM® Test and evaluating ways to leverage their large and growing pregnancy datasets to boost shareholder value through new products and partnerships.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2023

Historical avgQ2 2023

-1.9%

Avg return

Earnings day

-3.5%

Avg return

5 days after

-3.3%

Avg return

30 days after

36%

8 / 22 earnings

Positive

+14.3%

Q3 2022

Best reaction

-11.7%

Q1 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-3.7%-8.0%+18.1%
Q4 2025-7.7%+6.3%+20.4%
Q3 2025+1.7%+8.5%+19.0%
Q1 2025-11.7%-2.1%-35.4%
Q4 2024-5.1%-2.2%-17.9%
Q3 2024-0.3%-2.7%-3.9%
Q2 2024+0.0%-1.2%-2.2%
Q1 2024+3.3%-4.0%-13.6%
Q4 2023+3.4%+1.1%+7.7%
Q3 2023-3.2%-6.4%+130.9%
Q2 2023+0.8%-10.1%-39.9%
Q1 2023-0.8%-2.8%-13.0%
Q4 2022-10.0%-9.5%-22.3%
Q3 2022+14.3%+11.1%-4.0%
Q2 2022-4.1%-6.3%-27.3%
Q1 2022-7.6%-17.1%-32.7%
Q4 2021+3.6%+0.3%-39.3%
Q3 2021+0.3%-0.8%-8.2%
Q3 2020+0.3%-0.8%-8.2%
Q2 2021-4.8%-9.9%+0.0%
Q1 2021-4.8%-9.9%+0.0%
Q4 2020-4.8%-9.9%+0.0%
Q2 2020
Q1 2020

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro